ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 250 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $237,575 | +4.8% | 14,620 | +101.9% | 0.00% | – |
Q4 2023 | $226,778 | +5.0% | 7,243 | -45.1% | 0.00% | – |
Q3 2022 | $216,000 | +9.6% | 13,202 | -5.8% | 0.00% | – |
Q2 2022 | $197,000 | -60.9% | 14,012 | -32.7% | 0.00% | -100.0% |
Q1 2022 | $504,000 | +50.9% | 20,815 | +45.7% | 0.00% | 0.0% |
Q4 2021 | $334,000 | +44.0% | 14,290 | +2.4% | 0.00% | – |
Q3 2021 | $232,000 | -36.1% | 13,956 | -6.3% | 0.00% | -100.0% |
Q2 2021 | $363,000 | -9.9% | 14,891 | -4.7% | 0.00% | 0.0% |
Q1 2021 | $403,000 | -74.7% | 15,631 | -47.5% | 0.00% | -75.0% |
Q4 2020 | $1,591,000 | +44.8% | 29,753 | +11.7% | 0.00% | +33.3% |
Q3 2020 | $1,099,000 | +95.2% | 26,648 | +129.3% | 0.00% | +50.0% |
Q2 2020 | $563,000 | -2.9% | 11,622 | -15.3% | 0.00% | 0.0% |
Q1 2020 | $580,000 | -55.0% | 13,722 | -54.4% | 0.00% | -50.0% |
Q4 2019 | $1,289,000 | +8.0% | 30,122 | -9.1% | 0.00% | 0.0% |
Q3 2019 | $1,193,000 | +29.8% | 33,141 | -3.6% | 0.00% | +33.3% |
Q2 2019 | $919,000 | -0.3% | 34,366 | +0.1% | 0.00% | 0.0% |
Q1 2019 | $922,000 | +59.8% | 34,338 | -3.7% | 0.00% | +50.0% |
Q4 2018 | $577,000 | -6.6% | 35,658 | +19.7% | 0.00% | 0.0% |
Q3 2018 | $618,000 | -52.2% | 29,782 | -64.8% | 0.00% | -60.0% |
Q2 2018 | $1,292,000 | -20.7% | 84,607 | +16.6% | 0.01% | -28.6% |
Q1 2018 | $1,630,000 | -25.1% | 72,534 | +0.3% | 0.01% | -22.2% |
Q4 2017 | $2,177,000 | +20.9% | 72,314 | +51.2% | 0.01% | +12.5% |
Q3 2017 | $1,801,000 | +159.1% | 47,811 | +91.9% | 0.01% | +100.0% |
Q2 2017 | $695,000 | -14.9% | 24,915 | +4.9% | 0.00% | 0.0% |
Q1 2017 | $817,000 | -10.8% | 23,756 | -25.2% | 0.00% | -33.3% |
Q4 2016 | $916,000 | +137.3% | 31,756 | +161.8% | 0.01% | +200.0% |
Q3 2016 | $386,000 | +55.6% | 12,131 | +54.5% | 0.00% | 0.0% |
Q2 2016 | $248,000 | +56.0% | 7,852 | +37.7% | 0.00% | +100.0% |
Q1 2016 | $159,000 | -18.9% | 5,702 | +3.6% | 0.00% | -50.0% |
Q4 2015 | $196,000 | +59.3% | 5,502 | +47.6% | 0.00% | +100.0% |
Q3 2015 | $123,000 | +7.0% | 3,727 | +5.7% | 0.00% | 0.0% |
Q1 2015 | $115,000 | +2.7% | 3,525 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $112,000 | -30.9% | 3,525 | -46.0% | 0.00% | -50.0% |
Q3 2014 | $162,000 | +102.5% | 6,525 | +85.1% | 0.00% | +100.0% |
Q2 2014 | $80,000 | -82.3% | 3,525 | -83.8% | 0.00% | -85.7% |
Q1 2014 | $452,000 | +693.0% | 21,825 | +848.9% | 0.01% | +600.0% |
Q4 2013 | $57,000 | -9.5% | 2,300 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $63,000 | +1160.0% | 2,300 | +666.7% | 0.00% | – |
Q2 2013 | $5,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |